Clinical trial
Nebulizer Delivery of Intranasal Scopolamine
NCT04999449 is registered in ClinicalTrials.gov with Dartmouth-Hitchcock Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nebulizer Delivery of Intranasal Scopolamine
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 24, 2022
- Completion date
- May 7, 2025
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
motion sickness, scopolamine